Skip to main content
. Author manuscript; available in PMC: 2015 May 13.
Published in final edited form as: Vaccine. 2014 Mar 6;32(23):2732–2739. doi: 10.1016/j.vaccine.2014.02.043

Figure 3.

Figure 3

Figure 3

a). Non inferiority of a Single High Dose Versus a Single Standard Dose of MVA. Confidence intervals are shown for mean peak titer differences (PRNT log2.5 scale, ELISA log2 scale) between one HD and one SD prior to 2nd vaccination using per protocol population. Dashed vertical line indicates non-inferiority margin.

b). Non inferiority of a Single High Dose Versus Two Single Standard Doses of MVA. Confidence intervals are shown for mean peak titer differences (PRNT log2.5 scale, ELISA log2 scale) between two SDs and one HD all timepoints using per protocol population. Dashed vertical line indicates non-inferiority margin.